Trial Profile
Antiretroviral Activity and Tolerability of Once Daily Etravirine in Treatment-Naive Adults With HIV-1 Infection
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Feb 2024
Price :
$35
*
At a glance
- Drugs Etravirine (Primary) ; Emtricitabine/tenofovir disoproxil fumarate
- Indications HIV-1 infections
- Focus Therapeutic Use
- 11 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 20 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 12 Dec 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.